These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
699 related items for PubMed ID: 25575682
1. Cypermethrin Stimulates GSK3β-Dependent Aβ and p-tau Proteins and Cognitive Loss in Young Rats: Reduced HB-EGF Signaling and Downstream Neuroinflammation as Critical Regulators. Maurya SK, Mishra J, Abbas S, Bandyopadhyay S. Mol Neurobiol; 2016 Mar; 53(2):968-982. PubMed ID: 25575682 [Abstract] [Full Text] [Related]
2. Exposure to As-, Cd-, and Pb-mixture induces Aβ, amyloidogenic APP processing and cognitive impairments via oxidative stress-dependent neuroinflammation in young rats. Ashok A, Rai NK, Tripathi S, Bandyopadhyay S. Toxicol Sci; 2015 Jan; 143(1):64-80. PubMed ID: 25288670 [Abstract] [Full Text] [Related]
3. Cypermethrin induces astrocyte apoptosis by the disruption of the autocrine/paracrine mode of epidermal growth factor receptor signaling. Maurya SK, Rai A, Rai NK, Deshpande S, Jain R, Mudiam MK, Prabhakar YS, Bandyopadhyay S. Toxicol Sci; 2012 Feb; 125(2):473-87. PubMed ID: 22048644 [Abstract] [Full Text] [Related]
4. Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study. Zhang ZX, Zhao RP, Wang DS, Wang AN. Exp Gerontol; 2016 Nov; 84():88-95. PubMed ID: 27612601 [Abstract] [Full Text] [Related]
5. FLZ alleviates the memory deficits in transgenic mouse model of Alzheimer's disease via decreasing beta-amyloid production and tau hyperphosphorylation. Bao XQ, Li N, Wang T, Kong XC, Tai WJ, Sun H, Zhang D. PLoS One; 2013 Nov; 8(11):e78033. PubMed ID: 24223757 [Abstract] [Full Text] [Related]
6. Chronic cerebral hypoperfusion-induced impairment of Aβ clearance requires HB-EGF-dependent sequential activation of HIF1α and MMP9. Ashok A, Rai NK, Raza W, Pandey R, Bandyopadhyay S. Neurobiol Dis; 2016 Nov; 95():179-93. PubMed ID: 27431094 [Abstract] [Full Text] [Related]
7. Neuroprotective effects of regulators of the glycogen synthase kinase-3beta signaling pathway in a transgenic model of Alzheimer's disease are associated with reduced amyloid precursor protein phosphorylation. Rockenstein E, Torrance M, Adame A, Mante M, Bar-on P, Rose JB, Crews L, Masliah E. J Neurosci; 2007 Feb 21; 27(8):1981-91. PubMed ID: 17314294 [Abstract] [Full Text] [Related]
8. Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing. Wen Y, Planel E, Herman M, Figueroa HY, Wang L, Liu L, Lau LF, Yu WH, Duff KE. J Neurosci; 2008 Mar 05; 28(10):2624-32. PubMed ID: 18322105 [Abstract] [Full Text] [Related]
9. Targeting CCR3 to Reduce Amyloid-β Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer's Disease. Zhu C, Xu B, Sun X, Zhu Q, Sui Y. Mol Neurobiol; 2017 Dec 05; 54(10):7964-7978. PubMed ID: 27878757 [Abstract] [Full Text] [Related]
10. Isorhynchophylline ameliorates cognitive impairment via modulating amyloid pathology, tau hyperphosphorylation and neuroinflammation: Studies in a transgenic mouse model of Alzheimer's disease. Li HQ, Ip SP, Yuan QJ, Zheng GQ, Tsim KKW, Dong TTX, Lin G, Han Y, Liu Y, Xian YF, Lin ZX. Brain Behav Immun; 2019 Nov 05; 82():264-278. PubMed ID: 31476414 [Abstract] [Full Text] [Related]
11. The participation of insulin-like growth factor-binding protein 3 released by astrocytes in the pathology of Alzheimer's disease. Watanabe K, Uemura K, Asada M, Maesako M, Akiyama H, Shimohama S, Takahashi R, Kinoshita A. Mol Brain; 2015 Dec 04; 8(1):82. PubMed ID: 26637371 [Abstract] [Full Text] [Related]
12. GSK3β is involved in promoting Alzheimer's disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor proteinNL-F/NL-F knock-in mice. Jiang M, Zhang X, Yan X, Mizutani S, Kashiwazaki H, Ni J, Wu Z. Brain Behav Immun; 2021 Nov 04; 98():1-12. PubMed ID: 34391814 [Abstract] [Full Text] [Related]
17. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease. Kirouac L, Rajic AJ, Cribbs DH, Padmanabhan J. eNeuro; 2017 Nov 04; 4(2):. PubMed ID: 28374012 [Abstract] [Full Text] [Related]
18. Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset. Dionísio PA, Amaral JD, Ribeiro MF, Lo AC, D'Hooge R, Rodrigues CM. Neurobiol Aging; 2015 Jan 04; 36(1):228-40. PubMed ID: 25443293 [Abstract] [Full Text] [Related]
19. Amyloid-beta neurotoxicity in organotypic culture is attenuated by melatonin: involvement of GSK-3beta, tau and neuroinflammation. Hoppe JB, Frozza RL, Horn AP, Comiran RA, Bernardi A, Campos MM, Battastini AMO, Salbego C. J Pineal Res; 2010 Apr 04; 48(3):230-238. PubMed ID: 20136701 [Abstract] [Full Text] [Related]
20. A neural cell adhesion molecule-derived peptide reduces neuropathological signs and cognitive impairment induced by Abeta25-35. Klementiev B, Novikova T, Novitskaya V, Walmod PS, Dmytriyeva O, Pakkenberg B, Berezin V, Bock E. Neuroscience; 2007 Mar 02; 145(1):209-24. PubMed ID: 17223274 [Abstract] [Full Text] [Related] Page: [Next] [New Search]